Dividend.com: McDonald's Sellin' It

August Was a Tasty Month for McDonald's

McDonald's(MCD Quote) is reporting that August revenue was terrific, as the company posted a big rise in global same-store sales this morning.

The fast-food chain said its worldwide same-store sales, or sales at locations open at least a year, jumped 8.5% during the month. In Europe, same-store sales climbed 11.6%. Performance was particularly strong in the U.K., France, and Germany. Same-store sales rose 10% in the Asia-Pacific, Middle East and Africa division, as the company was able to benefit from strong Olympic sponsorship promotions.

We initiated coverage on June 9 with a recommendation, when the shares were trading at $56.95. We think MCD shares are a good buy on any pullbacks, as the company has been upping its dividend substantially the last four years. Besides that, the company is simply outperforming the rest of the food company chains. The company has a dividend yield of 2.40%, based on last night's closing stock price of $62.42.

McDonald's is a "Recommended" dividend stock, holding a Dividend.com Rating of 3.8 out of 5 stars.

Pfizer Suffers Drug Setback, but a Deal May be in the Works

Pfizer(PFE Quote) announced today that it will globally withdraw all Dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.S. new drug application and the European marketing authorization application.

The company plans to conduct an additional Phase III clinical trial with the antibiotic drug Dalbavancin, used in the treatment of adults with complicated skin and skin structure infections caused by Gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).